Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Hand Foot Syndrome in Sickle Cell Anemia
source: Family Practice Notebook
year: 2018
summary/abstract:Hand Foot Syndrome in Sickle Cell Anemia:
II. Epidemiology
Often the first vaso-Occlusion crisis finding in young children
Occurs in up to 50% of children with Sickle Cell Anemia by the age of 2 years
Rare over age 4 years old
III. Pathophysiology
A. Not to be confused with Hand Foot Syndrome that occurs with certain Chemotherapy agents in non-sickle disease
B. Occurs in Sickle Cell Anemia with vaso-Occlusion
C. Caused by infarction of Bone Marrow
1. Metacarpal or Metatarsal Bones and phalanges
IV. Symptoms
Painful swelling and tenderness of either the hand or foot
Digits may appear mildly erythematous
+myBinderRelated Content
-
Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Si...BACKGROUND: Sickle cell disease (SCD) is...
-
First systemic evidence for safety of tPA in stroke patients with sickle cell diseaseIn the largest report on acute stroke in...
-
Prevention of Conversion to Abnormal Transcranial Doppler With Hydroxyurea in Sickle Cell Anemia: A Phase III Intern...Children with sickle cell anemia (SCA) a...
-
The Role of Sleep Impairments on Pain Severity in Adults With Sickle Cell DiseaseSleep is a complex process and impairmen...
-
Randomized Trials Needed to Assess Benefits of Salmonella Vaccines in SCD Patients, Study SaysRandomized controlled trials are needed ...
-
A multiple drug approach to preventing sickle cell crisisSickle cell disease is characterized by ...
-
New Guidelines for Managing Sickle Cell Disease Presented at ACP Internal Medicine MeetingNew guidelines for therapeutic strategie...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.